KHTRF
Price
$4.72
Change
-$0.00 (-0.00%)
Updated
Aug 27 closing price
Capitalization
460.99M
ORGO
Price
$5.12
Change
+$0.28 (+5.79%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
649.51M
69 days until earnings call
Interact to see
Advertisement

KHTRF vs ORGO

Header iconKHTRF vs ORGO Comparison
Open Charts KHTRF vs ORGOBanner chart's image
Knight Therapeutics
Price$4.72
Change-$0.00 (-0.00%)
Volume$800
Capitalization460.99M
Organogenesis Holdings
Price$5.12
Change+$0.28 (+5.79%)
Volume$4.47K
Capitalization649.51M
KHTRF vs ORGO Comparison Chart in %
Loading...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KHTRF vs. ORGO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KHTRF is a Buy and ORGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (KHTRF: $4.72 vs. ORGO: $4.84)
Brand notoriety: KHTRF and ORGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KHTRF: 15% vs. ORGO: 64%
Market capitalization -- KHTRF: $460.99M vs. ORGO: $649.51M
KHTRF [@Pharmaceuticals: Generic] is valued at $460.99M. ORGO’s [@Pharmaceuticals: Generic] market capitalization is $649.51M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KHTRF’s FA Score shows that 0 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • KHTRF’s FA Score: 0 green, 5 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ORGO is a better buy in the long-term than KHTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KHTRF’s TA Score shows that 3 TA indicator(s) are bullish while ORGO’s TA Score has 3 bullish TA indicator(s).

  • KHTRF’s TA Score: 3 bullish, 3 bearish.
  • ORGO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, KHTRF is a better buy in the short-term than ORGO.

Price Growth

KHTRF (@Pharmaceuticals: Generic) experienced а +1.29% price change this week, while ORGO (@Pharmaceuticals: Generic) price change was +5.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.00%. For the same industry, the average monthly price growth was +11.42%, and the average quarterly price growth was +84.24%.

Reported Earning Dates

ORGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.00% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORGO($650M) has a higher market cap than KHTRF($461M). ORGO (63.75) and KHTRF (62.66) have similar P/E ratio . ORGO YTD gains are higher at: 51.250 vs. KHTRF (30.748). KHTRF has higher annual earnings (EBITDA): 52M vs. ORGO (3.19M). KHTRF has more cash in the bank: 116M vs. ORGO (73.1M). ORGO has less debt than KHTRF: ORGO (40.8M) vs KHTRF (105M). ORGO has higher revenues than KHTRF: ORGO (429M) vs KHTRF (385M).
KHTRFORGOKHTRF / ORGO
Capitalization461M650M71%
EBITDA52M3.19M1,630%
Gain YTD30.74851.25060%
P/E Ratio62.6663.7598%
Revenue385M429M90%
Total Cash116M73.1M159%
Total Debt105M40.8M257%
FUNDAMENTALS RATINGS
KHTRF vs ORGO: Fundamental Ratings
KHTRF
ORGO
OUTLOOK RATING
1..100
4776
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9194
PRICE GROWTH RATING
1..100
4739
P/E GROWTH RATING
1..100
9710
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KHTRF's Valuation (72) in the null industry is in the same range as ORGO (76) in the Financial Conglomerates industry. This means that KHTRF’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's Profit vs Risk Rating (93) in the Financial Conglomerates industry is in the same range as KHTRF (100) in the null industry. This means that ORGO’s stock grew similarly to KHTRF’s over the last 12 months.

KHTRF's SMR Rating (91) in the null industry is in the same range as ORGO (94) in the Financial Conglomerates industry. This means that KHTRF’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's Price Growth Rating (39) in the Financial Conglomerates industry is in the same range as KHTRF (47) in the null industry. This means that ORGO’s stock grew similarly to KHTRF’s over the last 12 months.

ORGO's P/E Growth Rating (10) in the Financial Conglomerates industry is significantly better than the same rating for KHTRF (97) in the null industry. This means that ORGO’s stock grew significantly faster than KHTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KHTRFORGO
RSI
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
35%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
39%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNSCX21.090.05
+0.24%
Natixis Vaughan Nelson Select C
DBIVX10.83N/A
N/A
DWS Global Macro S
CSXRX55.43N/A
N/A
Calvert US Large Cap Core Rspnb Idx R6
PAHVX7.19N/A
N/A
PGIM Jennison NextGeneration Glb Opps R6
FOPCX21.84N/A
N/A
Fidelity Advisor Intl Sm Cap Opps C

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and PLSH have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and PLSH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
N/A
PLSH - KHTRF
25%
Poorly correlated
N/A
OVATF - KHTRF
24%
Poorly correlated
N/A
BHC - KHTRF
23%
Poorly correlated
+1.39%
ORGO - KHTRF
22%
Poorly correlated
+0.41%
ESALF - KHTRF
21%
Poorly correlated
N/A
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+0.41%
ANIP - ORGO
47%
Loosely correlated
-0.01%
PRGO - ORGO
47%
Loosely correlated
+0.67%
ANIK - ORGO
33%
Poorly correlated
-1.61%
AMRX - ORGO
31%
Poorly correlated
-0.21%
ACET - ORGO
29%
Poorly correlated
+2.57%
More